SMTL ID : 6enq.1

Structure of human PPAR gamma LBD in complex with Lanifibranor (IVA337)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

homo-dimer

Ligands

1 x BJB: 4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl]butanoic acid(Non-covalent)

BJB.1: 19 residues within 4Å: Chain A: L.33, I.86, G.89, C.90, Q.91, R.93, S.94, I.131, Y.132, L.135, L.138, V.144, L.145, I.146, S.147, E.148, G.149, M.169, K.172 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.138 Hydrogen bonds: A:E.148, A:G.149 Water bridges: A:R.93 Salt bridges: A:R.93

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Boubia, B. et al., Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) alpha / gamma / delta Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate. J. Med. Chem. (2018)

Release Date

2018-03-14

Peptides

Peroxisome proliferator-activated receptor gamma: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Peroxisome proliferator-activated receptor gamma